Editor-in-Chief of The Annals, a journal that has been at the forefront of pharmacotherapy for4 decades. The rich history and legacy of thejournal weredescribed in theJanuary 2006 issue. We are pleased to highlight the growth and maturation of clinical pharmacy specialties and subspecialties throughout this year to celebrate the 40th anniversary of thejournal.
Don Francke, a pharmacy pioneer, set high standards for the journal in 1967as its founding editor. I believe he would be satisfiedwith the evolutionof the journal under the editorship and leadership of his protege, HarveyWhitney Jr. I have been fortunate to have had mentoring and support of Harvey in the past and am enthusiastic about working closely with him as Editor Emeritus during the coming years.
The primarygoal of the journal is to advance"safe, effective, and economical use of medications in patients." This goal will continue to be met by publishing novel, high-quality research papers and evidence-based review articles. I am happyto share some of our currentdata with you. The numberof manuscript submissions to thejournal has been rising steadily and has doubled since 2000. Any journal would like to be in this position, as it allows us to be more selective and publish a variety of articles. The peer review process for manuscriptsis being streamlined and strengthened. The median time from manuscript submission to online publicationis just 6.3 months, substantially shorter than 9 months in 2000. Almost all manuscripts are now submitted to the journal online. We strive to achieve a balance between online efficiency and personal touchfor peerreview and authorcorrespondence. All articles appear first on "ArticlesAhead of Print," providing immediate electronic access to TheAnnals' content several weeks before the printcopy arrives.
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It is a pleasure to be part of a superb team of editors and staff. We will continue to enhance the quality of our journal with the commitment and support of our talented editorial board, referees, and authors. The submission of clinically significant research articles, as well as comprehensive and critical reviews on pharmacotherapy, will be of highest priority. These are the typesof articles that expand the knowledge of our readers about the optimal use of medications in patients and stimulate further research in the field. Therapeutic Controversies and Editorials or Opinions on contemporary issues in pharmacy will continue to be of interest. Only Case Reports of new or unique findings, with probable or definite causality, will be considered for publication.
Each issueof thejournal should contain articles'ofinterest to everyone amongour readership: practitioners, educators, and researchers. I started reading the journal as a PharmDstudent in 1975and it has improved my effectiveness in practice, teaching, and research. The articles in the journal should help us in improving medication-related health outcomes and quality of life among our patients. I am confident that.we can continue to enhance the quality of ourjournal with your activeinvolvement and with contributions from both seasoned and new authors and experienced referees. We hope to receive some of your best articles for publication in TheAnnals.
I am grateful to Don McLeod, my residency preceptor, who emphasized the importance of sharing knowledge through publications, and to Harvey for teaching me the art and science of editorship during my involvement with The Annalsas SeniorEditorsince 1995. It has also beena great learning experience to work with many of you, my colleagues at Ohio State,and with the pharmacy associations, especiallyAmerican Association of Colleges of Pharmacy, American College of Clinical Pharmacy, American Pharmaceutical Association, and the American Societyof Health-SystemPharmacists, and theirrespective journal editors. I
The Annals of Pharmacotherapy • 2006February, Volume 40 • 321 lookforward to ourcontinued collaborations to address variousissues of common interest to advance ourprofession.
It is exciting to have this opportunity to serveas Editorin-Chief of The Annals, andI would verymuchenjoyhearing from you.We wouldwelcome your suggestions to enhance the qualityof our journal to make a positive impact on humanhealth andwell-being throughout the world.
Mllap C Nahata MS PharmD, Editor-In-Chief 
